OGDHL silencing promotes hepatocellular carcinoma by reprogramming glutamine metabolism.
J Hepatol. 2020 May;72(5):909-923. doi: 10.1016/j.jhep.2019.12.015. Epub 2019 Dec 30.
J Hepatol. 2020.
PMID: 31899205